25 related articles for article (PubMed ID: 1331346)
1. Human autopsy-tissue distribution of menogaril and its metabolites.
Stewart DJ; Grewaal D; Green RM; Goel R; Mikhael N; Montpetit VA; Redmond D; Earhart R
Cancer Chemother Pharmacol; 1993; 32(5):373-8. PubMed ID: 8339388
[TBL] [Abstract][Full Text] [Related]
2. New agents in the treatment of primary brain tumors.
Taylor SA
J Neurooncol; 1994; 20(2):141-53. PubMed ID: 7807191
[TBL] [Abstract][Full Text] [Related]
3. High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience.
Fine HA; Antman KH
Bone Marrow Transplant; 1992 Oct; 10(4):315-21. PubMed ID: 1330152
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of weekly intravenous menogaril in the treatment of recurrent astrocytomas in adults.
Stewart DJ; Hugenholtz H; DaSilva VF; Benoit BG; Richard MT; Verma S; Earhart R; Robillard L
J Neurooncol; 1992 Jun; 13(2):183-8. PubMed ID: 1331346
[TBL] [Abstract][Full Text] [Related]
5. Response and progression in recurrent malignant glioma.
Hess KR; Wong ET; Jaeckle KA; Kyritsis AP; Levin VA; Prados MD; Yung WK
Neuro Oncol; 1999 Oct; 1(4):282-8. PubMed ID: 11550320
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of oral menogaril as first line chemotherapy for advanced breast cancer: a National Cancer Institute of Canada Clinical Trials Group study.
Stewart DJ; Eisenhauer EA; Skillings J; Pritchard KI; Buckman R; VAndenberg T; Verma S; Aitken S; Norris B
Ann Oncol; 1992 Mar; 3(3):201-4. PubMed ID: 1534021
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of menogaril in metastatic adenocarcinoma of the prostate. A Southwest Oncology Group study.
Taylor SA; Blumenstein BA; Stephens RL; Crawford ED; Pistone B; Hill JB
Invest New Drugs; 1994; 12(1):67-70. PubMed ID: 7960610
[TBL] [Abstract][Full Text] [Related]
8. Combined intra-arterial and systemic chemotherapy for recurrent malignant brain tumors.
Watne K; Hannisdal E; Nome O; Hager B; Hirschberg H
Neurosurgery; 1992 Feb; 30(2):223-7. PubMed ID: 1312230
[TBL] [Abstract][Full Text] [Related]
9. Menogaril: a new anthracycline agent entering clinical trials.
McGovren JP; Nelson KG; Lassus M; Cradock JC; Plowman J; Christopher JP
Invest New Drugs; 1984; 2(4):359-67. PubMed ID: 6239835
[TBL] [Abstract][Full Text] [Related]
10. Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae.
Spigelman MK; Zappulla RA; Strauchen JA; Feuer EJ; Johnson J; Goldsmith SJ; Malis LI; Holland JF
Cancer Res; 1986 Mar; 46(3):1453-7. PubMed ID: 3510725
[TBL] [Abstract][Full Text] [Related]
11. The role of chemotherapy in the treatment of gliomas in adults.
Stewart DJ
Cancer Treat Rev; 1989 Sep; 16(3):129-60. PubMed ID: 2695239
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of weekly intravenous administration of menogaril to adults with solid tumors.
Stewart DJ; Maroun JA; Verma S; Perrault D; Earhart RH
Am J Clin Oncol; 1989 Dec; 12(6):511-8. PubMed ID: 2531540
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of oral menogaril administered on a once weekly schedule.
Stewart DJ; Verma S; Maroun JA; Robillard L; Earhart RH
Invest New Drugs; 1990 Feb; 8(1):43-52. PubMed ID: 2140564
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]